Solstice Advanced Materials, Inc.

What they do

Solstice manufactures low global warming potential refrigerants, blowing agents, aerosol propellants, cleaning solvents, high-barrier pharmaceutical packaging, and provides conversion services for the nuclear energy sector through its RAS segment. The ESM segment supplies sputtering targets, high-strength fibers (Spectra), and high-purity life science chemicals (Fluka, Hydranal) to semiconductor, defense, pharmaceutical, and construction markets. As of June 30, 2026, the company operated 20 manufacturing sites and 4 standalone R&D sites, serving over 3,000 customers in ~120 countries.

Revenue drivers

• Refrigerants & Applied Solutions (RAS) — Largest segment; 12% net sales growth in Q2 2026, driven by LGWP refrigerants, blowing agents, and nuclear conversion services.
• Electronic & Specialty Materials (ESM) — 8% net sales growth in Q2 2026, supported by sputtering targets, Spectra fibers, and life science chemicals.
• Nuclear conversion services — Double-digit growth in Q2 2026, part of RAS, benefiting from focus on nuclear energy.
• Healthcare packaging (Aclar) — Double-digit growth in Q2 2026, high-barrier pharmaceutical packaging under RAS.

Recent performance

Q2 2026 net sales were $1,148 million, up 11% YoY, with net income of $119 million (diluted EPS $0.75). Adjusted EBITDA was $290 million (25.3% margin), down 218 bps YoY due to plant turnaround timing and prior-year production credits. For the six months ended June 30, 2026, operating cash flow was $461 million and free cash flow $248 million. Full-year 2025 revenue was $3.89B with net income of $237.0M (diluted EPS $1.49).

Strategy

The company focuses on organic growth in high-growth end markets (nuclear, semiconductor, healthcare), disciplined cost management, and targeted capital expenditures—capex up 35% in H1 2026 to drive long-term growth. It plans to complete the acquisition of Element Solutions, a cash-and-stock deal announced July 6, 2026, with a $4.685B bridge commitment from Goldman Sachs. Management aims to build a scaled advanced materials platform aligned with trends in AI, data centers, nuclear energy, and semiconductor manufacturing.

Risks

• Spin-off integration and standalone costs — The company has limited history as an independent public company and faces higher standalone operating costs and net interest expense that reduced Q2 net income.
• Element Solutions acquisition risks — The proposed acquisition is subject to shareholder and regulatory approvals and may not close as expected; the company assumes a significant new debt commitment.
• Regulatory and environmental exposure — Chemical manufacturing and nuclear energy conversion are subject to complex government regulations, potential environmental liabilities, and changing public perceptions.
• Macroeconomic and supply chain volatility — Inflation, tariffs, raw material price fluctuations, and geopolitical instability could increase costs or disrupt operations and sales.

Outlook

For full-year 2026, management raised guidance to net sales of $4,125-$4,185 million, Adjusted EBITDA of $1,035-$1,055 million, and Adjusted diluted EPS of $2.75-$2.95. The Element Solutions acquisition is expected to close in the first half of 2027, subject to approvals. The company also declared a quarterly dividend of $0.075 per share for Q3 2026.